The treatment efficacy of pegylated interferon plus ribavirin therapy in chronic hepatitis C patients with mixed genotype 1/2 infection
碩士 === 高雄醫學大學 === 臨床醫學研究所 === 102 === Background Pegylated interferon (peginterferon) and ribavirin combination therapy remains the standard-of-care for patients with chronic hepatitis C virus (HCV) infection in the vast majority of countries. HCV genotype has been suggested to be the most powerful...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/28513837707540501311 |